Inventor
VISCOMI GIUSEPPE CLAUDIO
IT38 patents
⚠️ This page may combine multiple inventors who share the name “VISCOMI GIUSEPPE CLAUDIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALFA WASSERMANN SPA
12 patentsUS7906542B2Mar 15, 2011
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
ALFA WASSERMANN SPA40 citations96
US9271968B2Mar 1, 2016
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ALFA WASSERMANN SPA14 citations92
US8853231B2Oct 7, 2014
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
ALFA WASSERMANN SPA15 citations92
US8835452B2Sep 16, 2014
Polymorphic forms α, β and γ of rifaximin
ALFA WASSERMANN SPA15 citations92
US8741904B2Jun 3, 2014
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ALFA WASSERMANN SPA20 citations92
US7902206B2Mar 8, 2011
Polymorphic forms α, β and γ of rifaximin
ALFA WASSERMANN SPA28 citations92
US7923553B2Apr 12, 2011
Processes for the production of polymorphic forms of rifaximin
ALFA WASSERMANN SPA18 citations84
US9938298B2Apr 10, 2018
Solvated crystal form of rifaximin, production, compositions and uses thereof
ALFA WASSERMANN SPA2 citations67
US9452157B2Sep 27, 2016
Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof
ALFA WASSERMANN SPA5 citations66
US6866782B2Mar 15, 2005
Process for the purification of pharmacologically active proteins through cationic exchange chromatography
ALFA WASSERMANN SPA11 citations66
US9498442B2Nov 22, 2016
Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
ALFA WASSERMANN SPA1 citations50
US10258657B2Apr 16, 2019
Therapeutic and nutritional compositions for functional gastrointestinal disorders
ALFA WASSERMANN SPA0 citations40
VISCOMI GIUSEPPE CLAUDIO
11 patentsUS8193196B2Jun 5, 2012
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
VISCOMI GIUSEPPE CLAUDIO40 citations96
US8173801B2May 8, 2012
Processes for the production of polymorphic forms of rifaximin
VISCOMI GIUSEPPE CLAUDIO14 citations92
US8158781B2Apr 17, 2012
Polymorphic forms α, β and γ of rifaximin
VISCOMI GIUSEPPE CLAUDIO27 citations92
US8158644B2Apr 17, 2012
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
VISCOMI GIUSEPPE CLAUDIO26 citations92
US8518949B2Aug 27, 2013
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
VISCOMI GIUSEPPE CLAUDIO25 citations91
US8404704B2Mar 26, 2013
Use of polymorphic forms of rifaximin for medical preparations
VISCOMI GIUSEPPE CLAUDIO12 citations90
US8568782B2Oct 29, 2013
Gastroresistant pharmaceutical formulations containing rifaximin
VISCOMI GIUSEPPE CLAUDIO24 citations88
US8748447B2Jun 10, 2014
Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
VISCOMI GIUSEPPE CLAUDIO5 citations81
US8318763B2Nov 27, 2012
Rifamycin derivatives
VISCOMI GIUSEPPE CLAUDIO5 citations69
US10258610B2Apr 16, 2019
Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections
VISCOMI GIUSEPPE CLAUDIO0 citations43
US8987231B2Mar 24, 2015
Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved
VISCOMI GIUSEPPE CLAUDIO1 citations39
ALFASIGMA SPA
6 patentsUS11241452B2Feb 8, 2022
Oral compositions for the treatment of gastroesophageal reflux
ALFASIGMA SPA0 citations55
US10703763B2Jul 7, 2020
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ALFASIGMA SPA0 citations51
US10280177B2May 7, 2019
Use of polyols to obtain stable polymorphous forms of rifaximin
ALFASIGMA SPA0 citations49
US10285944B2May 14, 2019
Gastroresistant pharmaceutical formulations containing rifaximin
ALFASIGMA SPA0 citations47
US10428086B2Oct 1, 2019
Solvated crystal form of rifaximin, production, compositions and uses thereof
ALFASIGMA SPA0 citations46
US10793925B2Oct 6, 2020
Lactobacillus paracasei for the production of conjugated linoleic acid, nutritional and pharmaceutical preparations containing it and uses thereof
ALFASIGMA SPA0 citations43